The short version
- Why people research itAntimicrobial, biofilm and gut-immune support.
- What the evidence isUsed in the research community for chronic infection and biofilm-associated conditions.
- What to watchSkin or joint flare in an autoimmune condition.
How LL-37 works
Innate-immune antimicrobial peptide — disrupts microbial membranes and modulates inflammation and wound healing.
LL-37 is the only cathelicidin humans make, and it is not primarily an antibiotic. It is a signaling molecule that happens to be able to kill bacteria.
How it is made. The CAMP gene encodes a precursor, hCAP18, that is stored in neutrophil granules and secreted by epithelia. The mature 37-residue peptide is released by proteolytic cleavage of that precursor at the site where it is needed.
- Injectable
Research on LL-374 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
Human trials exist and are small. Not noise.
Correlative data
Used in the research community for chronic infection and biofilm-associated conditions. Injection-site reactions are the most consistent report, which the mechanism predicts.
How the mechanism reads
The only human cathelicidin — an endogenous antimicrobial peptide that disrupts bacterial membranes directly and also modulates immune signaling and promotes angiogenesis. Vitamin D upregulates its expression, which is one of the better-supported links between vitamin D status and infection.
MechanisticMembrane disruption is not selective, which is why high concentrations irritate host tissue too.
Mechanistic
Sources
- Chernomordik F, et al. Impaired tolerance to the autoantigen LL-37 in acute coronary syndrome. Frontiers in Immunology 2023 · PMID 37051254
- Martín Monreal MT, et al. Characterization of circulating extracellular traps and immune responses to citrullinated LL37 in psoriasis. Frontiers in Immunology 2023 · PMID 38173716
- Popa AD, et al. Cathelicidin: Insights into Its Impact on Metabolic Syndrome and Chronic Inflammation. Metabolites 2024 · PMID 39728453
- Lao J, et al. Serum LL-37 and inflammatory cytokines levels in psoriasis. Immunity, Inflammation and Disease 2023 · PMID 36988247
- Aloul KM, et al. Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis. Frontiers in Immunology 2022 · PMID 35634307
- White JH. Emerging Roles of Vitamin D-Induced Antimicrobial Peptides in Antiviral Innate Immunity. Nutrients 2022 · PMID 35057465
LL-37 safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Autoimmune disease such as psoriasis or lupus, since LL-37 is a known human autoantigen.
- Active or past cancer, because its effect on tumor growth varies by tissue.
- Active infection being treated, where an antimicrobial peptide alters inflammation.
- Pregnancy, since cathelicidin shapes placental immunity and was never given repeatedly.
What’s expected
- Membrane-disrupting antimicrobial activity plus pro-healing signals.
- Local redness, pain or a small hard lump at the site.
- An immune response that varies between people.
Watch for
- Skin or joint flare in an autoimmune condition.
- Fever or swelling at the site.
- Breathing difficulty or hives after use.
Labs that tell you it’s working
- ANA (Antinuclear Antibodies, IFA): an autoantibody read, relevant to an autoantigen being injected repeatedly.
- hs-CRP: the inflammatory response to the peptide.
- TNF-Alpha (Tumor Necrosis Factor): LL-37 is linked to TNF and psoriasis cytokine loops.
Human cathelicidin antimicrobial peptide that disrupts membranes and modulates inflammation; it is a known autoantigen in psoriasis and lupus. PMID 37051254 PMID 36988247 PMID 38173716
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
LL-37 FAQ4 common questions
- Is LL-37 approved for human use?
- No. LL-37 is a research compound.
- What is LL-37 researched for?
- Antimicrobial, biofilm and gut-immune support.
- Which labs show whether it's doing anything?
- ANA; hs-CRP; TNF-Alpha: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for LL-37: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.




